Sertraline
Treatment-resistant Schizophrenia
Consorcio Centro de Investigación Biomédica en Red (CIBER)Small moleculePhase 4 / ApprovedActive
BB
64/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 49/ 100
- Competitive Position
- 89/ 100
Competitive context
6 Active assets in the Treatment-resistant Schizophrenia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Olanzapine Dr. Stavroula Rakitzi | Phase 4 | BB |
Risperdal Dr. Stavroula Rakitzi | Phase 4 | BB |
CITALOPRAM Consorcio Centro de Investigación Biomédica en Red (CIBER) | Phase 4 | BB |
Cipralex Consorcio Centro de Investigación Biomédica en Red (CIBER) | Phase 4 | BB |
NW-3509 Newron Pharmaceuticals SPA | Phase 3 | B |
View all 9 →
Same molecule, other indications
Sertraline is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →